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Summary

The enzyme coproporphyrinogen oxidase (copro’gen oxidase) converts coproporphyrinogen-III
(C-III) to protoporphyrinogen-IX via an intermediary monovinyl porphyrinogen. The A ring isomer coproporphyrinogen-IV (C-IV) has previously been shown to be a substrate for copro’gen oxidase derived from avian erythrocytes. In contrast to the authentic substrate (C-III) where only a
small amount of the monovinyl intermediate is detected, C-IV gives rise to a monovinyl intermediate that accumulates before being converted to an isomer of protoporphyrinogen-IX. No kinetic studies have been carried out using the purified human copro’gen oxidase to evaluate its ability to process both the authentic substrate as well as analogs.
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Background:

Materials/Methods: Therefore, purified, cloned human copro’gen oxidase was incubated with C-III or C-IV at 37oC
with various substrate concentrations (from 0.005 µM to 3.5 µM). The Km (an indication of molecular recognition) and Kcat (turnover number) values were determined.
The Km value for total product formation was about the same with either C-III or C-IV indicating
the same molecular recognition. However, the catalytic efficiency (Kcat/Km) of the enzyme for total product formation was not more than two fold higher using C-III relative to C-IV.

U

Results:

Conclusions:

Since the Km values are about the same for either substrate and the total Kcat/Km values are within
two fold of each other, this could correlate with the increase of severity of porphyrias with monovinyl accumulation. The ability of the increased levels of C-IV to compete with the authentic substrate has important implications for clinical porphyrias.
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Coproporphyrinogen oxidase (copro’gen oxidase; EC
1.3.3.3) is the sixth enzyme in the biosynthetic pathway for
the production of heme. Coproporphyrinogen-III (C-III),
the authentic substrate for the enzyme copro’gen oxidase,
undergoes two sequential oxidative decarboxylations at the
A and B ring propionates to produce first a monovinyl product and then a divinyl product (Figure 1A).
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Porphyrias are a group of clinical disorders, either genetic or acquired, that are characterized by accumulation of
one or more type of porphyrins in tissues as well as higher levels of excretion in the urine and/or feces. These
patients are generally characterized with mild to severe
mental retardation, photosensitivity, and problems in
the liver and/or bone marrow. Thus, understanding the
enzymes involved in the heme biosynthesis pathway and
their ability to process both the authentic substrates and
analogs of these substrates is important in helping to develop clinical therapies for porphyrias. Defects in the various
enzymes of the synthetic pathway have been correlated with
various classes of porphyrias but much work yet remains.

with the correct sequence of substituents for the second “B
ring” propionate group to undergo oxidative decarboxylation. The Lash et al. paper also models the active site with
C-IV leaving the active site and re-entering prior to the second oxidative decarboxylation [11]. This isomer of the authentic substrate has the sequence of the methyl and propionate groups on ring A switched, giving the molecule a
plane of symmetry that is absent in C-III, and also providing two sequences of substituents that can be recognized at
the active site. However, the active site model predicts that
once the first oxidative decarboxylation has occurred, the
second propionate side chain cannot be correctly orientated until the intermediate has dissociated from the binding pocket, flipped over, and reentered into the active site.
This prediction provided a tentative explanation for the
differences in the observed kinetics using both substrates
by Jackson et al. [4]. Since C-IV can be processed as a substrate by normal (wildtype) copro’gen oxidase, this would
result in a divinyl product with a concomitant accumulation of a monovinyl species. We speculate that the accumulation of both the mono- and divinyl products from C-IV
in the mitochondria could then be correlated with clinical
symptoms of the patients with harderoporphyria, resulting
from the defect in a previous enzyme rather than in the
copro’gen oxidase enzyme. However, the active site model
was designed from results observed using crude preparations
of copro’gen oxidase from avian erythrocytes. As yet there
have been no reports on the kinetics for C-IV metabolism
using highly purified human enzyme preparations. In this
work, experiments were performed using purified preparations of the cloned human enzyme. The kinetic constants
(Km, Kcat, and Kcat/Km) were determined using non-linear regression under initial velocity (vo) conditions using
either C-III or C-IV as substrate.
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Harderoporphyria is a disorder often characterized by an
accumulation of monovinyl porphyrins in the body and
considered to be related to mutations in the gene encoding copro’gen oxidase. In addition, C-III and its isomer coproporphyrinogen-IV (C-IV) have been isolated from these
types of patients [1]. Yet, C-IV also has been reported in the
urine of patients with a defect in the enzyme 5-aminolevulinic acid dehydratase [2]. Kühnel et al. [1] also reported the
presence of C-IV in the urine of normal people, although
in much lower amounts.
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Modified porphyrinogens have been used to probe the active site of copro’gen oxidase. C-IV was first found to be a
substrate for ox-liver copro’gen oxidase by Porra and Falk
in 1964 [3], and was subsequently shown to be converted
to protoporphyrinogen-XIII via a monovinyl intermediate
(Figure 1B). Jackson et al., using crude enzyme preparations
from chicken red blood cells, reported that the monovinyl
intermediate from C-IV accumulated to about 40% total
porphyrinogen at intermediary incubation times, but was
eventually converted to the divinyl product [4]. This contrasts to time study experiments with authentic C-III where
accumulation of the monovinyl species, harderoporphyrinogen, was less than 10%. In addition, Buldain et al. showed
that incubations of C-IV with crude copro’gen oxidase preparations from duck blood, chicken blood and beef liver gave
divinyl product at a rate of only 10% that of C-III [5]. These
studies also showed that the type isomers coproporphyrinogen-I and coproporphyrinogen-II were not substrates for
copro’gen oxidase. On the bases of these and other investigations with substrate analogs [6–9], Lash et al. proposed
a substrate recognition model for the enzyme [10]. In this
model, there are requirements for the correct sequence of
the peripheral substituents around the macrocycle. In order to provide the correct “fit”, the sequence R Me-P Me-P
is required, where Me= –CH3, P= –CH2CH2CO2H and R is a
small nonpolar grouping such as Me, ethyl, or vinyl. When
C-III is metabolized, a vinyl group is generated at ring A.
The model predicts that the substrate remains in the active
site and can rotate through 90o and present the active site
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MATERIAL AND METHODS
Coproporphyrin-IV tetramethyl ester was prepared by the
cyclization of an a,c-biladiene intermediate following the
method reported by Lash et al. [10] and coproporphyrin
III tetramethyl ester was purchased from Aldrich Chemical
Company. Prior to reduction to the corresponding porphyrinogens, they were incubated overnight with 8.3 M HCl to
remove the methyl esters.
Enzyme assay
Using the micro method of Jones et al. [12], either the C-III
or C-IV porphyrinogen substrate (at a substrate concentration of 1 µM) was incubated with copro’gen oxidase at times
from 15 sec to 30 min. The final reaction volume was 310
µl which was made up of 300 µl of enzyme in 250 mM imidazole buffer, pH 7.2 and 10 µl of substrate. In another set
of experiments, substrate concentration was varied from 0
to 3.5 µM while holding the incubation time constant at 15
sec. For all reactions, the temperature was 37oC and the enzyme was 7.5 µg (0.20 nmoles) per incubate.
The reactions were stopped by addition of 3/7 (v/v) acetic
acid/ethyl acetate, followed by extraction and Fischer esterification overnight. In all experiments, a zero incubation time
control (addition of acetic acid/ethyl acetate before addition of substrate) was performed for comparison. Following
neutralization and extraction of the porphyrin methyl esters,
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Figure 1. (A) Oxidative decarboxylation of C-III to P-IX via harderoporphyrinogen. (B) Oxidative decarboxylation of C-IV to P-XIII via a monovinyl
intermediate.
they were evaluated using normal phase High Performance
Liquid Chromatography (HPLC; Beckman System Gold). A
normal phase column (Beckman Silica 5 µ, 4.6 mm × 25 cm)

was used with 35/65 (v/v) ethyl acetate/cyclohexane at a
flow rate of 1.3 ml per minute; eluates were evaluated spectrophotometrically at a wavelength of 404 nm. Data were
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Figure 3. SDS-PAGE gel to show the purity of the copro’gen oxidase.
In lane 1 are MW standards (97, 66, 45, 31, and 21 kDa),
lanes 2 and 3 are the supernatant (1 and 10 µl), lane 4 is
the Ni2+ column ﬂow through (10 µl), and lanes 5 and 6 are
the elution fractions (10 and 2 µl) containing the puriﬁed
enzyme.
at 35,000 × g for 30 minutes to pellet out the insoluble protein and membranes. The enzyme, which has the 6 his tag,
was isolated by the Ni2+ affinity procedure of Medlock and
Dailey [13]. Protein was analyzed by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) using the
Laemmli method [14] to test the purity and apparent molecular weight of the enzyme. The Bradford Protein Assay
[15] was used to evaluate the concentration of the enzyme.
Bovine Serum Albumin (BSA) was used as the standard.
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Figure 2. (A) Representative HPLC Chromatogram for the methyl
esters of the porphyrin products resulting from incubations
of C-III with pure copro’gen oxidase enzyme. (B) HPLC
Chromatogram for incubations with C-IV. Zero time
(unreacted) peaks shown with a dotted line and porphyrin
products isolated after incubation with enzyme with a
solid line. Peak A corresponds to methylene chloride (used
to dissolve the sample), peak B to protoporphyrin (divinyl
product), peak C to harderoporphyrin (monovinyl product),
and peak D to C-III or C-IV (unreacted substrates) in Figure
2A and 2B, respectively.
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analyzed using the Gold Nouveau Software and reported
as% product accumulated or subsequently converted to the
units of Medlock & Dailey [13]. Representative chromatograms are shown in Figure 2. Figure 2A shows product formation after zero or 20 minutes of incubation of C-III with
enzyme. Figure 2B shows product formation after zero or
20 minutes of incubation of C-IV with copro’gen oxidase.
In both cases the unreacted substrate, the monovinyl, and
the divinyl products are well resolved.
Isolation and purification of copro’gen oxidase
The human cloned enzyme was grown in E. coli strain
BL21(DE3)RIL (Stratagene) overnight at 37°C, with shaking at 250 rpm, in one-liter cultures using a medium consisting of 10 g tryptone, 5 g yeast extract, 10 g NaCl, and
100 mg ampicillin. Cells were isolated by centrifugation
(12,000 × g, 10 min) and lysed using the French hydraulic
pressure cell (20,000 psi). Then the lysate was centrifuged

RESULTS
Highly purified enzyme (30 mg/liter of cell culture) was obtained and only a single band of MW 37,700 Da was observed
by SDS-PAGE (Figure 3). Figure 4A shows the time dependent accumulation of divinyl, monovinyl, and total products
after incubation of 7.5 µg purified enzyme with the authentic C-III substrate (1 µM). Total product was calculated as
the sum of the monovinyl and divinyl products. Figure 4B
shows the time dependent accumulation of divinyl, monovinyl, and total products after incubation of C-IV under the
same conditions. These data are the mean of three separate
experiments. The range of high and low values about the
mean value was 5%. The data for the apparent linear portion of the lines (vo; % product/min) were evaluated by linear regression analysis. The initial velocity (vo) for monovinyl product accumulation is about 50 times faster (vo=106
relative to 2.4) with C-IV than with C-III. The initial velocity (vo) for divinyl product accumulation is about the same
(vo=28 relative to 35) with either substrate. C-IV total product accumulation reached an asymptote three to four fold
faster relative to C-III (vo=139 relative to 37). Using either
substrate, approximately the same final total product accumulation was evident.
Figure 5A shows vo (nmole product/min/pmole enzyme)
as a function of substrate over a concentration range of
0.005 to 3.5 µM using C-III. Figure 5B shows vo as a func-
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Figure 4. (A) Time course study with C-III as the substrate showing the time dependency of product accumulation. (B) Time course with C-IV
showing the time dependency of product accumulation. Triangles represent total product, squares show divinyl product, and circles
indicate of monovinyl product intermediate accumulation. All values were the mean of three separate experiments. The range of high and
low values about the mean was 5%.
B
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Figure 5. Eﬀect of substrate concentration on initial velocity (vo). (A) Substrate concentration curve with C-III as substrate. (B) Substrate
concentration curve with C-IV as substrate. Triangles represent total product, circles show divinyl product, and squares indicate monovinyl
product intermediate accumulation. The range of high and low values about the mean value of three separate experiments was 5%.
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Table 1. Kinetic constants of copro’gen oxidase for monovinyl, divinyl, and total product accumulated.

Monovinyl Product
Divinyl Product
Total Product

Substrate

Km (µM)

Kcat (min-1)

Kcat/Km

C-III

0.13

0.20

1.50

C-IV

0.65

1.70

2.60

C-III

0.70

3.30

4.70

C-IV

0.83

0.70

0.85

C-III

0.68

3.60

5.30

C-IV

0.78

2.60

3.30

tion of substrate over a concentration range of 0.005 to
3.5 µM using C-IV. The kinetic constants (Km, Kcat, and
Kcat/Km), using either substrate, are shown in Table 1. We
used the Michaelis-Menton assumptions and linear transformation of the data to obtain the kinetic constants, Km
and Kcat. For the production of monovinyl product there
is a 5 fold increase in Km when using C-IV as the substrate
relative to C-III, but more than an 8 fold increase in Kcat

using C-IV relative to C-III. For the divinyl product accumulated, there was essentially no difference in Km using either substrate, but almost a 5 fold increase in Kcat
using C-III relative to C-IV. The total product accumulation (the sum of the mono and divinyl products detected)
shows about the same Km for either substrate, and a 1.5
fold difference in Kcat values with C-III giving the higher
turnover number.

BR424
Electronic PDF security powered by ISL-science.com

Cooper CL et al – An a ring isomer as substrate for coproporphyrinogen oxidase

U
SE

Acknowledgements

BR

The cDNA encoding the 6x-histidine-tagged human
copro’gen oxidase was a generous gift from Dr. H.A. Dailey
of the University of Georgia (Athens, GA).

REFERENCES:

1. Kühnel A, Fross U, Jacob K, Doss MO: Studies on Coproporphyrin
Isomers in Urine and Feces in the Porphyrias. Clin Chim Acta, 1999;
282: 45–58
2. Jacob K, Doss MO: Composition of Urinary Coproporphyrin
Isomers I-IV in Human Porphyrias. Euro J Clin Chem Clin Biochem,
1993; 31: 617–24

O
N

Using purified wildtype human copro’gen oxidase, the results clearly demonstrate that C-IV is a good substrate for this
enzyme and binds in the active site with affinity comparable
to the normal pathway C-III substrate. This is not surprising
since C-IV can fit in either of two orientations that arise from
its plane of symmetry. Our data indicate that C-IV is a better
substrate for human enzyme than that of the other species
tested by Buldain et al. [5]. Jackson et al. [4] reported that
the monovinyl product from C-IV accumulates to about 40%
at intermediary times, but was eventually converted to divinyl
product. Our data show that the monovinyl product accumulates to 45% but was not apparently converted 100% into divinyl product with the human purified enzyme, even up to
30 minutes of incubation. For divinyl product accumulation,
C-III results in a higher turnover (larger Kcat) and more catalytic efficiency (larger Kcat/Km) with about the same binding affinity (Km) relative to C-IV. When considering the total product accumulation, both of the substrates are equally
processed under vo conditions. From the literature, a range
of Km values between 0.05 and 47 µM for C-III have been reported for this enzyme [13]. The Km values determined here
fall within the literature range. Our Km values were obtained
using highly purified enzyme at a very short incubation time,
while previous studies were conducted using a variety of enzyme sources, enzyme purities, incubation times, and assay
procedures which may explain the vast range of values.

authors speculated about which amino acids were involved in
the active site, this enzyme structure was solved in the absence
of substrate. This is likely due to the difficultly of keeping the
substrate in the reduced form recognized by the enzyme during crystallization. It is not clear whether the active site has yet
been correctly identified. Thus, the factors influencing substrate selectivity are still not completely understood.

A
L

DISCUSSION

3. Porra RJ, Falk JE: The Enzymatic Conversion of Coproporphyrinogen III into Protoporphyrinogen IX. Biochem J, 1964; 90: 69–75
4. Jackson AH, Elder GH, Smith SG: The Metabolism of Coproporphyrinogen-III into Protoporphyrin-IX. Int J Biochem, 1978; 9: 877–82

5. Buldain G, Hurst J, Frydman RB, Frydman B: Synthesis of the
Tricarboxylic Porphyrin Enzymically Formed from Coproporphyrinogen
IV. J Org Chem, 1977; 42: 2953–56

TI

CONCLUSIONS

U

C
A

When the total product accumulation of C-III was compared
with C-IV as a function of time, the apparent initial velocity using C-IV was about 3 fold higher than when using C-III. Thus,
the position of the propionate group on the A ring leads to different kinetics for the first oxidative decarboxylation for both
substrates. Different kinetics are also evident for the second
oxidative decarboxylation with the accumulation of the divinyl
product being much lower when using C-IV; C-IV resulted in a
5.5 fold lower Kcat/Km value relative to the C-III data.

ED

This copy is for educational u
This copy is for educational use only - distribution prohibited.
This copy is for educational use only - distribution prohibited.
This copy is for educational use only - distribution prohibited.
py is for educational use only - distribution prohibited.

Med Sci Monit, 2005; 11(11): BR420-425

These data support the model that there is a limiting step in
the second oxidative decarboxylation of C-IV. Thus our model, which predicts that C-IV comes completely out of the active site and flips over prior to re-entering the active site leading to divinyl product formation, is reasonable for the human
form of the enzyme. This then would allow either C-III or CIV to compete with the monovinyl intermediate for the active
site, thus lowering the divinyl product production from either
porphyrinogen. In vivo, this would increase the time that these
porphyrinogens reside in the cell especially in the mitochondrial compartment where copro’gen oxidase is located [16],
allowing them to spontaneously oxidize to the porphyrin form
not utilized by copro’gen oxidase. This could, therefore, increase the severity of the porphyria. Thus detection of monovinyl porphyrins in urine need not only be related to defects in
the copro’gen oxidase enzyme. Our data do not support or reject any of the proposed mechanisms for the oxidative decarboxylations performed by this enzyme [17]. The active site of
the enzyme has not yet been well established although several
crystal structures have been published [11]. An X-ray crystallographic structure for copro’gen oxidase has been recently
solved for the Saccharomyces cerevisiae oxygen dependant form
of the enzyme, but not the human form [11]. Although the

6. Al-Hazimi HMG, Jackson AH, Knight DW, Lash TD: Synthetic
and Biosynthetic Studies of Porphyrins. Part 7. The Action of
Coproporphyrinogen Oxidase of Coproporphyrinogen-IV: Synthesis
of Protoporphyrin-XIII, Mesoporphyrin-XIII, and Related Tricarboxylic
Porphyrins. J Chem Soc, Perkin Trans, 1987; 1: 265–76
7. Battersby AR, Hamilton AD, McDonald E et al: Biosynthesis
of Porphyrins and Related Macrocycles. Part 13. Structure of the
Protoporphyrin Isomer Derived from Coproporphyrinogen-IV
by Reaction of Beef-Liver Coproporphyrinogenase: Synthesis of
Protoporphyrin-XIII. J Chem Soc, Perkin Trans, 1980; 1: 1283
8. Lash TD, Hall T, Mani UN, Jones MA: Normal and Abnormal
Heme Biosynthesis. 3. Synthesis and Metabolism of Tripropionate
Analogues of Coproporphyrinogen-III: Novel Probes for the Active
Site of Coproporphyrinogen Oxidase. J Org Chem, 2001; 66: 3753–59
9. Lash TD, Keck ASIM, Mani UN, Jones MA: Unprecedented
Overmetabolism of a Porphyrinogen Substrate by Coproporphyrinogen
Oxidase. Bioorg Med Chem Lett, 2002; 12l: 1079–82

10. Lash TD, Mani UN, Drinan MA et al: Normal and Abnormal
Heme Biosynthesis. 1. Synthesis and Metabolism of Di- and
Monocarboxylic Porphyrinogens Related to CoproporphyrinogenIII and Harderoporphyrinogen: A Model for the Active Site of
Coproporphyrinogen Oxidase. J Org Chem, 1999; 64: 464–77
11. Phillips JD, Whitby FG, Warby CA et al: Crystal Structure of the Oxygendependant Coproporphyrinogen Oxidase (Hem13p) of Saccharomyces
cerevisiae. J Biol Chem, 2004; 279: 38960–68
12. Jones MA, Thientanavanich P, Anderson MD, Lash TD: Comparison of
Two Assay Methods for Activities of Uroporphyrinogen Decarboxylase and
Coproporphyrinogen Oxidase. J Biochem Biophys, 2003; 55: 241–49
13. Medlock AE, Dailey HA: Human Coproporphyrinogen Oxidase is Not
a Metalloprotein. J Biol Chem, 1996; 271: 32507–10
14. Laemmli UK: Cleavage of Structural Proteins During Assembly of the
Head of Bacteriophage T4. Nature, 1970; 227: 680–85
15. Bradford MM: A Rapid and Sensitive Method for the Quantitation of
Microgram Quantities of Protein Utilizing the Principle of Protein-Dye
Binding. Anal Biochem, 1976; 72: 248–54
16. Grandchamp B, Phung N, Nordmann Y: The Mitochondrial Localization
of Coproporphyrinogen III Oxidase. Biochem J, 1978; 176: 97–102
17. Akhtar M: The Modification of Acetate and Propionate Side Chains
During the Biosynthesis of Haem and Chlorophylls: Mechanistic
and Stereochemical Studies. In: The Biosynthesis of the Tetrapyrrole
Pigments. Chichester (Ciba Foundation Symposium 180). John Wiley
& Sons, 1994; 131–55

BR425
Electronic PDF security powered by ISL-science.com

EVALUATION & BENCHMARKING
PROFILED INFORMATION

O
N

NETWORKING & COOPERATION

C
A

TI

VIRTUAL RESEARCH GROUPS

U

Index
Copernicus
integrates

ED

This copy is for educational use only - distribution prohibited.
py is for educational use only - distribution prohibited.

U
SE

IndexCopernicus.com

www.

A
L

This copy is for educational u

Global Scientific Information Systems
for Scientists by Scientists

This copy is for educational use only - distribution prohibited.

This copy is for educational use only - distribution prohibited.

Index Copernicus

JOBS
STRATEGIC & FINANCIAL DECISIONS

IC Scientists

IC Virtual Research Groups [VRG]

Effective search tool for
collaborators worldwide.
Provides easy global
networking for scientists.
C.V.'s and dossiers on selected
scientists available. Increase
your professional visibility.

Web-based complete research
environment which enables researchers
to work on one project from distant
locations. VRG provides:

IC Patents

Scientific literature database,
including abstracts, full text,
and journal ranking.
Instructions for authors
available from selected journals.

Provides information on patent
registration process, patent offices
and other legal issues. Provides
links to companies that may want
to license or purchase a patent.
IC Grant Awareness

Effective search tool for
worldwide medical conferences
and local meetings.

PATENTS
CLINICAL TRIALS

IC Journal Master List

IC Conferences

GRANTS

Need grant assistance?
Step-by-step information on
how to apply for a grant. Provides
a list of grant institutions and
their requirements.

customizable
and individually

self-tailored electronic research
protocols and data capture tools,
statistical
analysis and report

creation tools,

profiled
information on literature,

publications, grants and patents
related to the research project,
administration
tools.


IC Lab & Clinical Trial Register
Provides list of on-going laboratory
or clinical trials, including
research summaries and calls for
co-investigators.

Electronic PDF security powered by ISL-science.com

